Evidence map›Paper›PMID 23277566›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain.

Pamela C Rodriguez, Daniela B Pereira, Anders Borgkvist, Minerva Y Wong, Candace Barnard, Mark S Sonders, Hui Zhang, Dalibor Sames, David Sulzer

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Multimodal Imaging Reveals Rapid Catecholamine Uptake and Release by Neutrophils.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Review
  4. Membrane Merger Dynamics in Exocytosis and Endocytosis.Advances in experimental medicine and biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Stable expression of the human dopamine transporter in N27 cells as an in vitro model for dopamine cell trafficking and metabolism.Toxicology in vitro : an international journal published in association with BIBRA · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. New optical methods for detecting monoamine neuromodulators.Current opinion in biomedical engineering · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Pamela C RodriguezDepartment of Chemistry, Columbia University, New York, NY 10027, USA.
Daniela B Pereira
Anders Borgkvist
Minerva Y Wong
Candace Barnard
Mark S Sonders
Hui Zhang
Dalibor Sames
David Sulzer
Columbia University · USNew York Psychoanalytic Society and Institute · US

Funding

The Presynaptic Vesicle Cycle for the Slow Acting Neurotransmitter SecretionP01DA010154 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EDWARDS, ROBERT H, KREITZER, ANATOL · 1995 to 2016
$14.7M
The Dopamine Synapse and Associative LearningR01DA007418 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI David Sulzer · 1999 to 2026
$9.4M
Design of Molecular Probes For Optical Imaging of Dopamine NeurotransmissionR01MH086545 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SAMES, DALIBOR · 2010 to 2013
$1.5M
Elucidating Aberrant Dopamine Release in SchizophreniaR21MH090356 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHANG, HUI · 2010 to 2011
$416k
NIDA NIH HHS P01 DA010154NIDA NIH HHS R01 DA007418NIDA NIH HHS R01DA07418NIMH NIH HHS R01 MH086545NIMH NIH HHS R01MH086545NIMH NIH HHS R21 MH090356
6 · The paper itself

Abstract

We recently introduced fluorescent false neurotransmitters (FFNs) as optical tracers that enable the visualization of neurotransmitter release at individual presynaptic terminals. Here, we describe a pH-responsive FFN probe, FFN102, which as a polar dopamine transporter substrate selectively labels dopamine cell bodies and dendrites in ventral midbrain and dopaminergic synaptic terminals in dorsal striatum. FFN102 exhibits greater fluorescence emission in neutral than acidic environments, and thus affords a means to optically measure evoked release of synaptic vesicle content into the extracellular space. Simultaneously, FFN102 allows the measurement of individual synaptic terminal activity by following fluorescence loss upon stimulation. Thus, FFN102 enables not only the identification of dopamine cells and their processes in brain tissue, but also the optical measurement of functional parameters including dopamine transporter activity and dopamine release at the level of individual synapses. As such, the development of FFN102 demonstrates that, by bringing together organic chemistry and neuroscience, molecular entities can be generated that match the endogenous transmitters in selectivity and distribution, allowing for the study of both the microanatomy and functional plasticity of the normal and diseased nervous system.

Indexed as

Fluorescent DyesAmphetamineAnimalsAxonsBrainCorpus StriatumDendritesDopamineDopamine Plasma Membrane Transport ProteinsHydrogen-Ion ConcentrationMaleMiceMice, Inbred C57BLMicroscopy, Fluorescence, MultiphotonPhotochemical ProcessesPresynaptic TerminalsAmphetamineDopamineDopamine Plasma Membrane Transport ProteinsFluorescent Dyes

Identifiers

PMID23277566
PMCPMC3549135
OpenAlexW2142768012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.